Retatrutide 40mg: High-Dose Triple Agonist Therapy)
The 40mg Retatrutide Pen is specifically designed for long-term weight maintenance and metabolic reset. As a triple-hormone receptor agonist, the 40mg dosage is being studied for its ability to significantly increase basal metabolic rate while providing maximum appetite suppression.
Clinical Expectations for the 40mg Titration
In high-intent clinical settings, the 40mg concentration allows for flexible dosing schedules.
- Metabolic Reset: Targeting the Glucagon receptor to burn fat during rest.
- Appetite Control: Dual GIP/GLP-1 activation for 24/7 satiety.
- Trial Results: Participants at high doses in Phase 2 trials showed unprecedented weight reduction of up to 24.2% in just 48 weeks.
Buying Retatrutide 40mg Pens Safely in the UK
We warn all high-intent buyers to avoid unregulated “grey market” 40mg pens. Authentic Retatrutide requires a strict cold-chain (2-8°C) from the laboratory to your door. Our clinic provides the only regulated pathway for legal access once the MHRA grants approval. Currently, we recommend Tirzepatide 40mg systems as the safest legal alternative.
FAQ
- When can I buy the Retatrutide 40mg Pen in the UK?
The 40mg pen is expected to be available following MHRA approval in late 2026/2027. We are currently accepting registrations for our priority clinical waitlist. - What is the projected price for Retatrutide 40mg?
Based on current Tirzepatide (Mounjaro) 15mg pricing, the 40mg Retatrutide multi-dose pen is projected to retail between £249 and £349 in the UK market.
- Is the 40mg dose safe for beginners?
No. Clinical protocols require a “titration” period, starting at lower doses (usually 2mg or 4mg) before moving up to the 40mg maintenance system.



Reviews
There are no reviews yet.